Polyphenols, Alkaloids, and Terpenoids Against Neurodegeneration: Evaluating the Neuroprotective Effects of Phytocompounds Through a Comprehensive Review of the Current Evidence
Enzo Pereira de Lima,
No information about this author
Lucas Fornari Laurindo,
No information about this author
Vitor Cavallari Strozze Catharin
No information about this author
et al.
Metabolites,
Journal Year:
2025,
Volume and Issue:
15(2), P. 124 - 124
Published: Feb. 13, 2025
Neurodegenerative
diseases
comprise
a
group
of
chronic,
usually
age-related,
disorders
characterized
by
progressive
neuronal
loss,
deformation
structure,
or
loss
function,
leading
to
substantially
reduced
quality
life.
They
remain
significant
focus
scientific
and
clinical
interest
due
their
increasing
medical
social
importance.
Most
neurodegenerative
present
intracellular
protein
aggregation
extracellular
deposition
(plaques),
such
as
α-synuclein
in
Parkinson's
disease
amyloid
beta
(Aβ)/tau
aggregates
Alzheimer's.
Conventional
treatments
for
conditions
incur
high
costs
are
related
the
development
several
adverse
effects.
In
addition,
many
patients
irresponsive
them.
For
these
reasons,
there
is
growing
tendency
find
new
therapeutic
approaches
help
patients.
This
review
intends
investigate
some
phytocompounds'
effects
on
diseases.
These
generally
increased
oxidative
stress
inflammation,
so
phytocompounds
can
prevent
treat
To
achieve
our
aim
provide
critical
assessment
current
literature
about
phytochemicals
targeting
neurodegeneration,
we
reviewed
reputable
databases,
including
PubMed,
EMBASE,
COCHRANE,
seeking
trials
that
utilized
against
conditions.
A
few
investigated
humans,
after
screening,
13
were
ultimately
included
following
PRISMA
guidelines.
compounds
include
polyphenols
(flavonoids
luteolin
quercetin,
phenolic
acids
rosmarinic
acid,
ferulic
caffeic
other
like
resveratrol),
alkaloids
(such
berberine,
huperzine
A,
caffeine),
terpenoids
ginkgolides
limonene).
The
gathered
evidence
underscores
caffeine,
ginkgolides,
primarily
anti-inflammatory,
antioxidant,
neuroprotective,
counteracting
neuroinflammation,
oxidation,
synaptic
dysfunctions,
which
crucial
aspects
intervention
various
conditions,
Alzheimer's
dementias,
depression,
neuropsychiatric
disorders.
summary,
they
show
use
improvements
cognition,
memory,
disinhibition,
irritability/lability,
aberrant
behavior,
hallucinations,
mood
Language: Английский
Role of Plant Phytochemicals: Resveratrol, Curcumin, Luteolin and Quercetin Indemyelination, Neurodegeneration, and Epilepsy
M Grabarczyk,
No information about this author
Weronika Justyńska,
No information about this author
Joanna Czpakowska
No information about this author
et al.
Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(11), P. 1364 - 1364
Published: Nov. 7, 2024
Polyphenols
are
an
important
group
of
biologically
active
compounds
present
in
almost
all
food
sources
plant
origin
and
primarily
known
for
their
anti-inflammatory
antioxidative
capabilities.
Numerous
studies
have
indicated
broad
spectrum
pharmacological
properties
correlations
between
increased
supply
the
human
diet
lower
prevalence
various
disorders.
The
positive
effects
polyphenols
application
mostly
discussed
terms
cardiovascular
system
well-being.
However,
recent
years,
they
also
increasingly
mentioned
as
prophylactic
therapeutic
factors
context
neurological
diseases,
being
able
to
suppress
progression
such
disorders
soothe
accompanying
symptoms.
Among
over
8000
compounds,
that
been
identified,
most
widely
examined
comprise
resveratrol,
curcumin,
luteolin
quercetin.
This
review
focuses
on
vitro
assessments,
animal
models
clinical
trials,
reflecting
actual
state
knowledge,
polyphenols'
medicinal
capabilities
epilepsy,
demyelinating
neurodegenerative
diseases
central
nervous
system.
Language: Английский
Phytotherapeutic options for the treatment of epilepsy: pharmacology, targets, and mechanism of action
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: May 24, 2024
Epilepsy
is
one
of
the
most
common,
severe,
chronic,
potentially
life-shortening
neurological
disorders,
characterized
by
a
persisting
predisposition
to
generate
seizures.
It
affects
more
than
60
million
individuals
globally,
which
major
burdens
in
seizure-related
mortality,
comorbidities,
disabilities,
and
cost.
Different
treatment
options
have
been
used
for
management
epilepsy.
More
30
drugs
approved
US
FDA
against
However,
one-quarter
epileptic
still
show
resistance
current
medications.
About
90%
low
middle-income
countries
do
not
access
medication.
In
these
countries,
plant
extracts
treat
various
diseases,
including
These
medicinal
plants
high
therapeutic
value
contain
valuable
phytochemicals
with
diverse
biomedical
applications.
multifactorial
disease,
therefore,
multitarget
approaches
such
as
or
extracted
are
needed,
can
target
multiple
pathways.
Numerous
shown
epilepsy
animal
models
targeting
receptors,
enzymes,
metabolic
could
be
humans
future;
however,
further
research
needed
study
exact
mechanism
action,
toxicity,
dosage
reduce
their
side
effects.
this
narrative
review,
we
comprehensively
summarized
species
purified
isolated
from
plants,
targets
Language: Английский
Flavonoids as therapeutic agents for epilepsy: unveiling anti-inflammatory and antioxidant pathways for novel treatments
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: Sept. 12, 2024
Epilepsy,
a
chronic
neurological
disorder
affecting
millions
globally,
is
often
exacerbated
by
neuroinflammation
and
oxidative
stress.
Existing
antiepileptic
drugs
primarily
manage
symptoms,
leaving
the
disease's
progression
largely
unaddressed.
Flavonoids,
ubiquitous
plant
metabolites
with
potent
anti-inflammatory
antioxidant
properties,
show
promise
in
epilepsy
treatment.
Unlike
conventional
therapies,
they
target
multiple
pathophysiological
processes
simultaneously,
offering
comprehensive
approach
to
this
complex
disorder.
This
review
explores
dual
role
of
flavonoids
mitigating
reducing
stress
through
various
molecular
pathways.
By
inhibiting
key
inflammatory
mediators
pathways
such
as
NF-κB,
MAPK,
JNK,
JAK,
offer
neuronal
protection.
They
enhance
body's
natural
defenses
modulating
enzyme
activities,
including
superoxide
dismutase,
catalase,
glutathione
peroxidase.
Moreover,
influence
crucial
response
like
PI3K/AKT,
Nrf2,
PKA.
Despite
their
therapeutic
promise,
low
bioavailability
poses
considerable
challenge.
However,
cutting-edge
strategies,
nanotechnology
chemical
modifications,
are
underway
improve
efficacy.
These
advancements
support
potential
valuable
addition
treatment
strategies.
Language: Английский